Search results for "Marker"

showing 10 items of 3799 documents

Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening

2019

REDISSEC-CARESS/CCR group.

Malemedicine.medical_specialtySurvivalColorectal cancerPerineural invasionAsymptomaticGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumorHumansMass ScreeningMedicineProspective StudiesColorectal carcinomas030212 general & internal medicineStage (cooking)Prospective cohort studyEarly Detection of CancerAgedNeoplasm StagingBiological markersbusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistrySurvival RateOncologySpain030220 oncology & carcinogenesisCohortScreeningT-stageFemaleSurgerymedicine.symptomColorectal NeoplasmsbusinessBody mass indexFollow-Up StudiesEuropean Journal of Surgical Oncology
researchProduct

Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dy…

2021

Abstract Background Some studies have suggested that patients with diabetes and foot complications have worse cardiovascular and cerebrovascular risk profiles, higher degrees of endothelial dysfunction and arterial stiffness and a higher inflammatory background than patients with diabetes without diabetic foot complications. Patients with diabetes mellitus have an alteration in the sympathovagal balance as assessed by means of heart rate variability (HRV) analysis, which is also related to the presence of endothelial dysfunction. Other studies suggest a possible role of inflammation coexisting with the alteration in the sympathovagal balance in favor of the atherosclerotic process in a mixe…

Malemedicine.medical_specialtySympathetic Nervous SystemSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismPopulationHyperemia030209 endocrinology & metabolism030204 cardiovascular system & hematologyGPI-Linked Proteins03 medical and health sciences0302 clinical medicineHeart RateLectinsHRV diabetic foot diabetesInternal medicineDiabetes mellitusmedicineDiseases of the circulatory (Cardiovascular) systemHumansOutpatient clinicHeart rate variabilityeducationReactive hyperemiaSerpinsAgedOriginal Investigationeducation.field_of_studybusiness.industryHeartVagus NerveMiddle Agedmedicine.diseaseDiabetic footDiabetic FootCross-Sectional StudiesDiabetes Mellitus Type 2RC666-701Case-Control StudiesArterial stiffnessCardiologyCytokinesFemaleEndothelium VascularSample collectionInflammation MediatorsCardiology and Cardiovascular MedicinebusinessBiomarkersCardiovascular Diabetology
researchProduct

A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence.

2007

The literature on immunosenescence has focused mainly on T cell impairment. With the aim of gaining insight into B cell immunosenescence, we investigated the serum immunoglobulin levels in a cohort of 166 subjects (20-106 years). Serum IgG (and IgG subclasses) were quantified by the nephelometric technique, IgE by CAP system fluorescence enzyme immunoassay, and IgD by radial immunodiffusion (RID). There was an age-related increase of IgG and IgA; the IgG age-related increase was significant only in men, but IgG1 levels showed an age-related increase both in men and women, whereas IgG3 showed an age-related increase only in men. IgE levels remain unchanged, whereas IgD and IgM serum levels d…

Malemedicine.medical_specialtyT cellNaive B cellLongevityImmunoglobulinsImmunoglobulin EImmunoglobulin DGeneral Biochemistry Genetics and Molecular BiologyImmune systemHistory and Philosophy of ScienceInternal medicinemedicineHumansB cellAgedAged 80 and overB-LymphocytesbiologyGeneral NeuroscienceImmunosenescenceEndocrinologymedicine.anatomical_structureImmunologybiology.proteinFemaleAntibodyImmunologic MemoryBiomarkers
researchProduct

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment

2006

Specific patterns of cortical glucose metabolism disturbances and increased CSF phospho-tau (p-tau(181)) concentrations could be demonstrated to predict cognitive decline and shift to dementia in amnestic mild cognitive impairment (MCI). But comparisons of both diagnostic tools have not been undertaken so far. The aim of the study was to compare (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) findings and CSF phospho-tau (p-tau(181)) measurements in the prediction of cognitive deterioration and conversion to dementia in MCI. During follow-up (mean 19 months) eight of 16 patients (50%) showed progressive cognitive decline, and four patients shifted to dementia. Patholog…

Malemedicine.medical_specialtyTau proteinNeuroscience (miscellaneous)tau ProteinsKaplan-Meier EstimateSeverity of Illness IndexStereotaxic TechniquesCentral nervous system diseaseImaging Three-DimensionalDegenerative diseaseFluorodeoxyglucose F18Internal medicinemental disordersSeverity of illnessImage Processing Computer-AssistedmedicineHumansDementiaRadiology Nuclear Medicine and imagingLongitudinal StudiesCognitive declineAgedPsychiatric Status Rating ScalesbiologyCognitive disorderPrognosismedicine.diseasePsychiatry and Mental healthPositron-Emission TomographyStereotaxic techniquebiology.proteinCardiologyDementiaFemaleCognition DisordersMental Status SchedulePsychologyNeuroscienceBiomarkersFollow-Up StudiesPsychiatry Research: Neuroimaging
researchProduct

Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics an…

2020

Background: Different studies have indicated that thiazide diuretics can increase the risk of developing type 2 diabetes (T2D). Therefore, in this study, we investigated whether switching from hydrochlorothiazide (HCTZ) to amlodipine resulted in ameliorating different cardiovascular and metabolic measures in hypertensive patients with or without T2D. Methods: This study [Diuretics and Diabetes Control (DiaDiC)] was a 6-week, single-blind, single-center randomized controlled trial. The first 20 normal glucose-tolerant, 20 prediabetic, and 20 T2D consecutive patients were randomized to continue the previous antihypertensive treatment with HCTZ (12.5-25 mg/day) or to switch from HCTZ to amlodi…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismSodium Chloride Symporter InhibitorsdiureticBlood PressureType 2 diabetesSettore MED/13 - EndocrinologiaInternal medicineInternal MedicineMedicineHumansSingle-Blind MethodAmlodipineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateThiazideAntihypertensive AgentsAgedtreatmentbusiness.industryDrug Substitutioncardiovascularfood and beveragesMiddle Agedmedicine.diseaseCalcium Channel BlockersDiabetes controlHydrochlorothiazideTreatment OutcomeDiabetes Mellitus Type 2ItalyHypertensionCardiologyFemaletype 2 diabetesAmlodipinethiazidebusinessEnergy MetabolismmetabolismBiomarkersmedicine.drugMetabolic syndrome and related disorders
researchProduct

Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Pat…

2020

Background Risk stratification among patients with coronary artery disease ( CAD ) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase‐type plasminogen activator receptor (su PAR ) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD . Methods and Results Plasma levels of su PAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography—including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main o…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial InfarctionRenal functionCoronary Artery Disease030204 cardiovascular system & hematologyKidneyRisk AssessmentReceptors Urokinase Plasminogen Activatorsoluble urokinase‐type plasminogen activator receptorTroponin CCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineSecondary PreventionmedicineHumanscardiovascular diseasesMyocardial infarctionReceptorAgedOriginal Research030304 developmental biologyUrokinase0303 health sciencesbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinC-Reactive ProteinHeart Disease Risk FactorsCardiologybiomarkerBiomarker (medicine)FemaleKidney DiseasesCardiology and Cardiovascular MedicinebusinessPlasminogen activatorBiomarkersGlomerular Filtration Ratemedicine.drugJournal of the American Heart Association
researchProduct

Short-term exposure to sublethal tebuconazole induces physiological impairment in male zebrafish (Danio rerio).

2010

Abstract The aim of the present study was to assess the physiological response of male zebrafish Danio rerio to the fungicide tebuconazole and recovery in fungicide-free water. Acute toxicity tests were carried out and the median lethal concentration (LC 50 ) from 24 to 96 h was calculated. The fish were exposed to a sublethal fungicide concentration of 230 μg/L for 7 or 14 days and allowed to recover for 7 or 14 more days, respectively. Whole-body levels of vitellogenins, triglycerides, cholesterol, glucose, lactate and proteins as well as the activities γ-glutamil transpeptidase (γ-GT), alanin aminotransferase (AlAT), alkaline phosphatase (AP) and lactate dehydrogenase (LDH) were assayed;…

Malemedicine.medical_specialtyTime FactorsHealth Toxicology and MutagenesisBiologyLethal Dose 50chemistry.chemical_compoundVitellogeninVitellogeninsFish physiologyInternal medicineLactate dehydrogenasemedicineToxicity Tests AcuteAnimalsZebrafishTebuconazoleBody WeightPublic Health Environmental and Occupational HealthGeneral MedicineEnvironmental ExposureRecovery of FunctionTriazolesLipid MetabolismPollutionAcute toxicityEnzymesFungicides IndustrialEndocrinologyGlucosechemistryToxicitybiology.proteinLactatesAlkaline phosphataseVitellogeninsBiomarkersEcotoxicology and environmental safety
researchProduct

Prognostic value of troponin I in atrial fibrillation

2021

To evaluate whether circulating cardiac troponin I (cTnI) levels are associated with worst outcomes in patients with atrial fibrillation (AF).Consecutive patients visiting the emergency room (ER) with a new episode of a previously diagnosed AF or a new diagnosis of AF during ER admission between January 1st, 2010 and December 31st, 2015, were enrolled in the study (n = 2617). After applying exclusion criteria and eliminating repeated episodes, 2013 patients were finally included. Of these, 1080 patients with at least one cTnI measurement in the ER were selected and classified into 4 groups according to cTnI quartiles: Q1 (n = 147) cTnI10 ng/L (Group 1); Q2 (n = 254): 10-19 ng/L (Group 2); Q…

Malemedicine.medical_specialtyTime FactorsHeart failureComorbidity030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicineTroponin ImedicineClinical endpointAtrial fibrillation Emergency Heart failure Mortality TroponinsTroponinsHumans030212 general & internal medicineRisk factorMortalityAdverse effectAgedRetrospective StudiesAged 80 and overbiologybusiness.industryTroponin IAtrial fibrillationMiddle AgedPrognosismedicine.diseaseTroponinAtrial fibrillationQuartileHeart failureEmergencybiology.proteinFemaleEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study

2020

Background Coronary heart disease is a leading cause of mortality worldwide. Iron deficiency, a frequent comorbidity of coronary heart disease, causes an increased expression of transferrin receptor and soluble transferrin receptor levels (sTfR) levels, while iron repletion returns sTfR levels to the normal physiological range. Recently, sTfR levels were proposed as a potential new marker of iron metabolism in cardiovascular diseases. Therefore, we aimed to evaluate the prognostic value of circulating sTfR levels in a large cohort of patients with coronary heart disease. Methods and Results The disease cohort comprised 3423 subjects who had angiographically documented coronary heart diseas…

Malemedicine.medical_specialtyTime FactorsIronMyocardial InfarctionCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentGastroenterologyCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineReceptors TransferrinmedicineHumansCoronary Heart Diseasesoluble transferrin receptorAgedOriginal Research030304 developmental biologySoluble transferrin receptorchemistry.chemical_classification0303 health sciencesbiologybusiness.industryMyocardiumMetabolismIron deficiencyMiddle AgedPrognosismedicine.diseaseComorbidityCoronary heart diseasechemistryTransferrinbiology.proteinbiomarkerBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of the American Heart Association
researchProduct

Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock.

2011

OBJECTIVE: Septic shock remains a serious disease with high mortality and increased risk of hospital-acquired infection. The prediction of outcome is of the utmost importance for selecting patients for therapeutic strategies aiming to modify the immune response. The aim of this study was to assess the capability of S100A9 messenger RNA in whole blood from patients with septic shock to predict survival and the occurrence of hospital-acquired infection. DESIGN: Cohort study. SETTING: Two intensive care units in a university hospital. SUBJECTS: The study included patients with septic shock (n = 166) and healthy volunteers (n = 44). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: For the pa…

Malemedicine.medical_specialtyTime Factors[SDV]Life Sciences [q-bio]Critical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineIntensive careHospital-acquired infectionmedicineCalgranulin BHumans030212 general & internal medicineRNA MessengerComputingMilieux_MISCELLANEOUS030304 developmental biologyAged0303 health sciencesCross InfectionSeptic shockbusiness.industryOdds ratioMiddle Agedmedicine.diseaseShock Septic3. Good health[SDV] Life Sciences [q-bio]Intensive Care Units[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieShock (circulatory)Predictive value of testsBiomarker (medicine)[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessBiomarkersCohort studyCritical care medicine
researchProduct